|
|||||
|
|
Results of inotuzumab ozogamicin,a CD22 monoclonal antibody,in refractory and relapsed acute lymphocytic leukemia |
|
| Authors: | Hagop Kantarjian MD Deborah Thomas MD Jeffrey Jorgensen MD Partow Kebriaei MD Elias Jabbour MD Michael Rytting MD Sergernne York RN Farhad Ravandi MD Rebecca Garris BA Monica Kwari RN Stefan Faderl MD Jorge Cortes MD Richard Champlin MD Susan O'Brien MD |
| Affiliation: | 1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, , Houston, Texas;2. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, , Houston, Texas;3. Department of Cellular Therapy and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, , Houston, Texas |
| Abstract: | |
| Keywords: | inotuzumab acute lymphocytic leukemia refractory relapsed monoclonal antibody |